Sana Biotechnology, Inc. (SANA)
NASDAQ: SANA · Real-Time Price · USD
1.650
+0.050 (3.13%)
At close: Dec 20, 2024, 4:00 PM
1.720
+0.070 (4.24%)
After-hours: Dec 20, 2024, 5:30 PM EST
Sana Biotechnology Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
TTM
| FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
Net Income | -305.81 | -283.26 | -269.48 | -355.93 | -285.31 | -130.78 | |
Depreciation & Amortization | 22.96 | 24.56 | 15.63 | 11.07 | 5.92 | 1.83 | |
Stock-Based Compensation | 39.17 | 35.53 | 38.34 | 22.36 | 5.83 | 1.5 | |
Other Operating Activities | 10.93 | -49.03 | -82.08 | 61.64 | 129.42 | 31.43 | |
Change in Accounts Payable | -2.24 | 1.03 | 1.06 | -0.27 | 1.98 | -0.42 | |
Change in Other Net Operating Assets | 7.03 | 17.58 | 6.48 | 10.07 | 4.17 | 10.93 | |
Operating Cash Flow | -227.95 | -253.58 | -290.05 | -251.05 | -137.98 | -85.52 | |
Capital Expenditures | -47.04 | -20.03 | -20.88 | -29.86 | -23.87 | -26.12 | |
Cash Acquisitions | - | - | - | - | - | -3.2 | |
Investment in Securities | 32.72 | 192.04 | 231.44 | -211.36 | -228.69 | -58.54 | |
Other Investing Activities | - | - | - | -4.57 | - | - | |
Investing Cash Flow | -14.33 | 172.01 | 210.56 | -245.8 | -252.56 | -87.86 | |
Issuance of Common Stock | 193.02 | 31.65 | 4.91 | 631.75 | 0.15 | 0 | |
Financing Cash Flow | 200.82 | 31.65 | 4.91 | 631.75 | 435.69 | 223.74 | |
Net Cash Flow | -41.45 | -49.92 | -74.58 | 134.9 | 45.14 | 50.36 | |
Free Cash Flow | -274.99 | -273.61 | -310.93 | -280.92 | -161.85 | -111.64 | |
Free Cash Flow Per Share | -1.24 | -1.41 | -1.65 | -1.69 | -12.44 | -22.77 | |
Levered Free Cash Flow | -187.32 | -199.92 | -135.45 | -138.16 | -166.01 | -86.98 | |
Unlevered Free Cash Flow | -187.32 | -199.92 | -135.45 | -138.16 | -166.01 | -86.98 | |
Change in Net Working Capital | 16.94 | 35.67 | 4.33 | -61.44 | -8.84 | -12.88 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.